Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Frontiers in Microbiology|November 22, 2019
Differential Culturability of <i>Mycobacterium tuberculosis</i> in Culture-Negative Sputum of Patients With Pulmonary Tuberculosis and in a Simulated Model of DormancyAzger Dusthackeer, Magizhaveni Balasubramanian, Govindarajan Shanmugam, et al.
The Journal of Infectious Diseases|February 13, 2019
Diverse Clinical Isolates of Mycobacterium tuberculosis Develop Macrophage-Induced Rifampin ToleranceKristin N Adams, Amit Kumar Verma, Radha Gopalaswamy, et al.
Nature Communications|July 5, 2020
Dual RNA-seq of Orientia tsutsugamushi informs on host-pathogen interactions for this neglected intracellular human pathogenBozena Mika-Gospodorz, Suparat Giengkam, Alexander J Westermann, et al.
Plos One|July 3, 2015
Lesion-Specific Immune Response in Granulomas of Patients with Pulmonary Tuberculosis: A Pilot StudySelvakumar Subbian, Liana Tsenova, Mi-Jeong Kim, et al.
Frontiers in Public Health|October 27, 2023
Comprehensive assessment of invalid and indeterminate results in Truenat MTB-RIF testing across sites under the national TB elimination program of IndiaRadha Gopalaswamy, Nishant Kumar, Himanshu Vashistha, et al.
Antioxidants (Basel, Switzerland)|April 23, 2022
Liposomal Glutathione Helps to Mitigate <i>Mycobacterium tuberculosis</i> Infection in the LungsNala Kachour, Abrianna Beever, James Owens, et al.
Journal of Medical Virology|March 23, 2022
SARS-CoV-2, SARS-CoV, and MERS-CoV encode circular RNAs of spliceosome-independent originShaomin Yang, Hong Zhou, Mingde Liu, et al.
Plos Pathogens|October 4, 2024
Fatty acid metabolism in neutrophils promotes lung damage and bacterial replication during tuberculosisPoornima Sankar, Ramon Bossardi Ramos, Jamie Corro, et al.
Plos One|October 19, 2023
Dynamics of temporal immune responses in nonhuman primates and humans immunized with COVID-19 vaccinesResmi Ravindran, Harsharonjit Kang, Cindy McReynolds, et al.
Medicina (Kaunas, Lithuania)|June 28, 2023
Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South IndiaRadha Gopalaswamy, Nandhini Palani, Dinesh Viswanathan, et al.
Pageof 15